Literature DB >> 19773672

Detection of colorectal cancer using ¹⁸F-FLT PET: comparison with ¹⁸F-FDG PET.

Yuka Yamamoto1, Reiko Kameyama, Kunihiko Izuishi, Ryusuke Takebayashi, Masanobu Hagiike, Masato Asakura, Reiji Haba, Yoshihiro Nishiyama.   

Abstract

OBJECTIVE: We investigated the feasibility of 3'-deoxy-3'-¹⁸F-fluorothymidine (FLT) positron emission tomography (PET) for the detection of colorectal cancer, in comparison with 2-deoxy-2-¹⁸F-fluoro-D-glucose (FDG) PET, and investigated correlation of the two radiotracers used with proliferative activity as indicated by Ki-67 index.
METHODS: A total of 26 patients with newly diagnosed colorectal cancer were examined with FLT PET and FDG PET. Tumor lesions were identified as areas of focally increased uptake, exceeding that of surrounding normal tissue. For semiquantitative analysis, the maximal standardized uptake value (SUV) was calculated.
RESULTS: In all 26 patients, colorectal cancers were detected by both FLT PET and FDG PET. The mean (± SD) values of FLT SUV in colon cancer (5.4 ± 2.4) and in rectal cancer (5.6 ± 1.3) were significantly lower than the corresponding values of FDG SUV (12.4 ± 6.3 and 12.5 ± 4.7, respectively) (P < 0.003). There was no significant correlation between Ki-67 index and either FLT SUV or FDG SUV.
CONCLUSION: Although uptake of FLT was found to be significantly lower than that of FDG, both FLT PET and FDG PET were able to detect colorectal cancers in all 26 patients. Neither of the two radiotracers used was correlated with proliferative activity.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19773672     DOI: 10.1097/MNM.0b013e328330294d

Source DB:  PubMed          Journal:  Nucl Med Commun        ISSN: 0143-3636            Impact factor:   1.690


  11 in total

1.  Diagnostic performance of ¹⁸F-fluorothymidine PET/CT for primary colorectal cancer and its lymph node metastasis: comparison with ¹⁸F-fluorodeoxyglucose PET/CT.

Authors:  Masatoyo Nakajo; Masayuki Nakajo; Yoriko Kajiya; Megumi Jinguji; Nobuaki Nishimata; Shunji Shimaoka; Tohru Nihara; Kuniaki Aridome; Sadao Tanaka; Yoshihiko Fukukura; Atushi Tani; Chihaya Koriyama
Journal:  Eur J Nucl Med Mol Imaging       Date:  2013-05-08       Impact factor: 9.236

2.  Correlations of (18)F-fluorothymidine uptake with pathological tumour size, Ki-67 and thymidine kinase 1 expressions in primary and metastatic lymph node colorectal cancer foci.

Authors:  Masatoyo Nakajo; Masayuki Nakajo; Yoriko Kajiya; Yuko Goto; Megumi Jinguji; Sadao Tanaka; Yoshihiko Fukukura; Atsushi Tani; Michiyo Higashi
Journal:  Eur Radiol       Date:  2014-08-13       Impact factor: 5.315

Review 3.  Current molecular imaging positron emitting radiotracers in oncology.

Authors:  Aizhi Zhu; Hyunsuk Shim
Journal:  Nucl Med Mol Imaging       Date:  2011-02-01

4.  Early detection of tumor response by FLT/microPET Imaging in a C26 murine colon carcinoma solid tumor animal model.

Authors:  Wan-Chi Lee; Chih-Hsien Chang; Chung-Li Ho; Liang-Cheng Chen; Yu-Hsien Wu; Jenn-Tzong Chen; Ying-Ling Wang; Te-Wei Lee
Journal:  J Biomed Biotechnol       Date:  2011-08-16

5.  Correlation between the Uptake of 18F-Fluorodeoxyglucose (18F-FDG) and the Expression of Proliferation-Associated Antigen Ki-67 in Cancer Patients: A Meta-Analysis.

Authors:  Sheng-Ming Deng; Wei Zhang; Bin Zhang; Yin-Yin Chen; Ji-Hui Li; Yi-Wei Wu
Journal:  PLoS One       Date:  2015-06-03       Impact factor: 3.240

6.  Assessment of response to neoadjuvant radiochemotherapy with F-18 FLT and F-18 FDG PET/CT in patients with rectal cancer.

Authors:  Gundula Rendl; Lukas Rettenbacher; Johannes Holzmannhofer; Lidwina Datz; Cornelia Hauser-Kronberger; Gerd Fastner; Dietmar Öfner; Felix Sedlmayer; Christian Pirich
Journal:  Ann Nucl Med       Date:  2014-12-11       Impact factor: 2.668

7.  A comparison of FLT to FDG PET/CT in the early assessment of chemotherapy response in stages IB-IIIA resectable NSCLC.

Authors:  John P Crandall; Abdel K Tahari; Rosalyn A Juergens; Julie R Brahmer; Charles M Rudin; Giuseppe Esposito; Deepa S Subramaniam; Michael V Knopp; Nathan C Hall; Prateek Gajwani; Jeffrey P Leal; Martin A Lodge; Joo H O; Edward W Gabrielson; Lalitha K Shankar; Richard L Wahl
Journal:  EJNMMI Res       Date:  2017-01-19       Impact factor: 3.138

8.  Limits of [18F]-FLT PET as a biomarker of proliferation in oncology.

Authors:  Eliot T McKinley; Gregory D Ayers; R Adam Smith; Samir A Saleh; Ping Zhao; Mary Kay Washington; Robert J Coffey; H Charles Manning
Journal:  PLoS One       Date:  2013-03-15       Impact factor: 3.240

9.  Repopulation of tumor cells during fractionated radiotherapy and detection methods (Review).

Authors:  Jia Yang; Jin-Bo Yue; Jing Liu; Jin-Ming Yu
Journal:  Oncol Lett       Date:  2014-03-21       Impact factor: 2.967

10.  Diagnostic accuracy of 18F-FDG PET/CT for detecting synchronous advanced colorectal neoplasia in patients with gastric cancer.

Authors:  Byung Wook Choi; Hae Won Kim; Kyoung Sook Won; Bong-Il Song; Kwang Bum Cho; Sung Uk Bae
Journal:  Medicine (Baltimore)       Date:  2016-09       Impact factor: 1.889

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.